Home Immunization with Palivizumab-A Randomized Pilot Study Describing Safety Aspects and Parents’ Preferences

Among prematurely born infants and newborns with chronic conditions, a respiratory syncytial virus (RSV) infection may cause (re-)admission and later respiratory complications. Therapeutic protection is possible with monthly injections of a specific monoclonal antibody, palivizumab, during RSV seaso...

Descripción completa

Detalles Bibliográficos
Autores principales: Ebersjö, Christina, Berggren Broström, Eva, Kull, Inger, Lindholm Olinder, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955059/
https://www.ncbi.nlm.nih.gov/pubmed/36832327
http://dx.doi.org/10.3390/children10020198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9955059/
https://www.ncbi.nlm.nih.gov/pubmed/36832327
http://dx.doi.org/10.3390/children10020198

Ejemplares similares